Side Effect of MS Medications: Ocrelizumab
Ocrelizumab (Ocrevus®) is a monoclonal antibody and belongs to the group of so-called B-cell-depleting therapies, which currently play a very important role in the immunotherapy of Multiple Sclerosis. They are used quite frequently. This article
Continue reading